Tc02v2_p002100.1

Overview
NameTc02v2_p002100.1
Unique NameTc02v2_p002100.1
Typepolypeptide
OrganismTheobroma cacao (cacao)
Sequence length3832
Properties
Property NameValue
NoteTc02v2_g002100~ Target of rapamycin~ unknown_gene~ complete
Productuncharacterized protein LOC18607246
Cross References
External references for this polypeptide
DatabaseAccession
GeneID18607246
GenbankXP_007041369.2
InterProIPR031559
InterProIPR003152
InterProIPR000403
InterProIPR011009
InterProIPR018936
InterProIPR011989
InterProIPR016024
Relationships

This polypeptide derives from the following mRNA feature(s):

Feature NameUnique NameSpeciesType
Tc02v2_t002100.1Tc02v2_t002100.1Theobroma cacaomRNA


Sequences
The following sequences are available for this feature:

polypeptide sequence

>Tc02v2_p002100.1 ID=Tc02v2_p002100.1|Name=Tc02v2_p002100.1|organism=Theobroma cacao|type=polypeptide|length=3832bp
MMQGLHHQQQQLAALLTVALPKDTTATATATSSSSSSFTPSTSTPTTTTT
PAVSTNSDESDSARLAAINSLHRAIRYPPNSILVAHSASFLAQGFSQLLS
DKSYSVRQAAAIAYGALCAVVCSIPIGSSGRQNHVMLGSLVDRFIGWALP
LLSNISAGDGTTELALEALREFLSVGDVGGIERYALSILKACQELLEDER
TSLTLLHRLLGVLTLISLKFSLSFQPHFLDIVDVLLGWALVPDLAESDRQ
VIMDSFLQFQKHWVGNLQFSLGLLFKFLGDMDVLLQDATHGTPQQFRRLL
ALLSCFCTVLQSTASGLLEMNLLEQISEPLSKMLPRLLGCLSVVGKKFGW
SKWIEDSWKCLTLLAEILRERFSTFYSLAVDILFQSLDLDSTSRLVGAGK
ITSFQVHGVLKTNLQLLSLQKLGLLPSSVQKILHFDAAISQLRLHPNHLV
TGSSAATYVFLLQHGNDEIVQQAMTLLTEELQLLKGLLGNILGHGEGVNS
VGDTRSYSKCELFALIKFDLKVLLTSVSLCGHNTLIVQPKNATLYLQRSE
NLIYFIIEKLNPFDLPIQFCVELQVNVIKTLDRLSMVKFLSKCSIRNQSG
HIPTGDVAAEKVLNDNSFRDVHSAMIVEYLRECGTLLGKALHVSSPVSVK
VVALEWVQRFCENLISICENSKMDTNFYEEFGYVSHFGNTIFSILEAAFD
REPKVRLHVTLALELLLQARLMHPLYFNSVSEVVLEKLGDPDNDIRNAYV
RLLSHVLLTTIYIYGIHHIGAFSNSRPRALMLGNNSNLYWKQVFSLKQLP
QQLNSQQLVSILSYISQRWKVPLSSWIQRLIHTCRSSKDGILGQLEETGI
LGVNDLWMDIKVEEDALEKLCFVNNLAGAWWAIHEAARYCISTRLRTNLG
GPTQTFAALERMLLDVAHVLQLDSEQNDGSLSIIGSSGAHLLPMRLLLDF
VEALKKNVYNAYEGSAVLPSASRQSSLFFRANKKVCEEWFSRICEPMMNA
GLALQCHDATIQYCTLRLQELKSLVMSAFKEKSQAQVTENLHNMKEKYIG
DILRVVQHMSLALCRNHQSEALIGLQKWVSVTFSPLLLDEDQSMNHNGIF
GPFQWITGLIYQAEGQYEKAASHFAHLLQTEESLSTMGSDGVQFAIARII
ESYTAVSDWKSLESWLLELQTLRAKHAGKSYSGALTTAGNEMNAIHALAR
FDEGDLQAAWAYLDLTPKSSSELTLDPKLALQRSEQMLLQALLLQIEGNV
DKVPHELQKAKSMLEEMLSVLPLDGLAEAAACATQLHCIFAFEEGYELTG
NQGKCQEHMASQGKSKLSQSVLSSYLQPLRPLIKGIHQDCNPWLKILRVY
RAIFPTSPVTLKLSMNLSSLARKQGNLMLANCLNSYVRDHVLSCSQERYP
NLLILNLQYEEILLLYAENKIEDAFVNIWSFLRPCLCSSALIVNDVDDGK
LKAKACLKLSNWLRRDYCSMSFENIVLRMLADLNVANVSSIGTGGHCFSD
MDLSSKLSLDVIIEEIVGTATKLSTQLCPTMAKSWISYASWCFSQAKSSV
VNQHEKCLHLYSFSPVLVSELAPERFKMTEDEIQGVESVIMPLFQERDDM
EHVDDRAEQWNFCSDPAEMLRTDNPSKALVQQVVDMMEAAAGAPGAENSG
GERLSATLTSQLRSSLQLASIGVEETDITYVIDKLIDVWWSLRKRRVSLF
GYAAHGFIQYLLHSSTKLCDGQLSGDVCEPLKQTAGSYTLRATLYVLHIL
LNYGLELKDTLEPDLSTVPLLSWQDVTPQLFARLSSHPEEVVRKQIEGLL
VMLAKLSPWSIVYPTLVDINAYEEKPSEELQHILGCLRELYPRLVQDVQL
VINELGNVTVLWEELWLSTLQDLHMDVMRRINVLKEEAARIAENATLNQS
EKNKINAAKYSAMMAPIVVALERRLASTSTKPETPHELWFHQEYKEQLKS
AILSFKTPPASAAALGDVWRPFDNIAASLASYQRKSSVSLGEVAPQLAML
SSSDVPMPGLEKQVTASESDGGRTSTLQGIVTIASFSEQVTILSTKTKPK
KLVILGSDGKTYTYLLKGREDLRLDARIMQLLQAINSFLHSSSTTNHNLL
GIRYYSVTPISGRAGLIQWVDNVTSIYSIFKSWQNRVQLAQLSALGAGNA
KNSVPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHEVKRKVLLDLMK
EVPKHLLHQELWCASEGFKAFSSKLKRYSRSVAAMSMVGHILGLGDRHLD
NILMDFSSGDVVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIE
GTFRANCEAVVGALRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGE
ERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLVTLPAVESTLERFGDVL
NQYELVSALFYRADQERSNLILHETSAKSIVAEATCNSEKTRASFEIQAR
EFNQAKNLVAEKAQQAASWIEQHGRILDALRGNLIPEINACINLSGMADA
LSLTSAVPVAGVPLTIVPEPTQAQCYDIDREVSQLISELDRGLSSAVMAL
QAYSLALQRVLPLNYLTTSAVHGWGQVLQLSANAVSSDILSLARRQAAEL
IAKVHGDNLEFMKSSHDDLCFKVEKYAVEIEKVEEECAELVNSIGTETES
KAKDRLMSAFMRYMQSAGLVRKEDANSSLQSGESKYDGTRASRTRGELEE
KKDKVLSVLSTAVRSLYDDVKHRVLDMYSHTGRAQNENSRLQSDLGTVFS
EFEEQVEKCILVAGFVNELWQQIGGDMLGVDRDLYYPKYYSEGNWASIFK
TILLCCKNLVGEMTEVVLPDVMRSAVSFNTEVMDAFGLISQIRGSVDTAL
EQLVEVELERASLVELEQNYFVKVGCITEQQLALEEAAMKGRDHLSWEEA
EELASQEEACRVQLDQLHRTWNQRDMRTSSLIKREAEIKNSLVSCENHFQ
SLINGEDFRESHHSRSKVLLAILVKPFSELESVDKALSSLSSSVAPRADE
IPNLVDFMSSGHSVSESVWNFGTLLSSHSFFIWKIGVLDAILDSCIHDVA
SSVDQNLGFEQLFNVVKRKLEIQLKEYLGRYLKIRVAPALLSWLDKENEH
LKLLTEGAKEPSTDHIRKDAMAVKRVQLMLEEYCNTHETARAARSAASLM
KRQVNELKEALRKTILEIVQMEWMHDVGLTHSHSSRILFQKFFSSDDELY
PIVLNLSRPKLLETMQAVVSKVARSIEGLQSCEHTSLAAEGQLERAMGWA
CGGPNSGGTGNSSSKASGIPPEFHDHLMRRRHLLQEAREKASNIVKICMS
ILEFEASRDGIFQIPREVYALSTGGDSRTWQQAYFSALTKLEVAYHSFTR
TEQEWKLAQSNMEVASSGLYSATNELCIASLKAKSASGDLQSTVLAMRNC
ACEASVALSAFARVSRGHTALTSESGSMLEEVLAITEDLHDVHNLGKEAA
AAHHSLMEDLSKANAILLPLESVLAKDVSAMTEAMARERETKMEVSPIHG
QAIYQSYGLRIRETCQTFKPSVPSLAFSVKELHSLLTRLARTASLHAGNL
HKALEGLGESQELKSQGISLSRPDLAGDATESDERAGESISTSGSGSTKD
FVGLTGLSLQDKEWISPPDSIGGSIAESGIISNGTSLSDSINDPAEVMEK
IWLVSNHKTANDSQNFVPSSQSDYDEISQSGQRSSNNMEMNNSDTSSVKS
ATGEPNEYLKAVASVNDEAVSAPLESSQPSNKENLDVKFGVKDEVSTSRK
VELGDEDHGVPVPNTHTASRIARGKNAYALSVLKRVEMKLDGQDITERRE
ISIAEQVDYLLKQATSVDNLCSMYEGWTPWI*
back to top
Annotated Terms
The following terms have been associated with this polypeptide:
Vocabulary: CC Functional Completeness
TermDefinition
completecomplete
Vocabulary: CC Evidence Code
TermDefinition
IC_1IC_1
Vocabulary: Genedb Products
TermDefinition
Target of rapamycinTarget of rapamycin
Vocabulary: Molecular Function
TermDefinition
GO:0004674protein serine/threonine kinase activity
GO:0005515protein binding
GO:0016301kinase activity
GO:0005488binding
Vocabulary: Biological Process
TermDefinition
GO:0000184nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
GO:0016310phosphorylation